Accelerate Diagnostics
AXDX
#11271
Rank
A$1.24 M
Marketcap
A$0.04929
Share price
0.00%
Change (1 day)
-96.98%
Change (1 year)

Operating Margin for Accelerate Diagnostics (AXDX)

Operating Margin as of November 2026 (TTM): -428.37%

According to Accelerate Diagnostics's latest financial reports and stock price the company's current Operating Margin is -428.37%. At the end of 2021 the company had an Operating Margin of -659.12%.

Operating Margin history for Accelerate Diagnostics from 2001 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-659.12%-5.9%
2020-700.43%-22.86%
2019-907.99%-41.57%
2018-1,554.06%2.17%
2017-1,521.07%-94.34%
2016-26,872.76%-13.18%
2015-30,951.02%20.03%
2014-25,786.89%-18.52%
2013-31,649.21%1306.37%
2012-2,250.42%6062.54%
2011-36.52%-234.04%
201027.24%-150.94%
2009-53.48%-84.87%
2008-353.37%-66.37%
2007-1,050.75%-26.25%
2006-1,424.83%242.18%
2005-416.40%-70.93%
2004-1,432.23%773.11%
2003-164.04%49.25%
2002-109.91%-49.57%
2001-217.95%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Thermo Fisher Scientific
TMO
16.48%-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
7.17%-101.67%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
14.13%-103.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
1.11%-100.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-97.64%-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
13.53%-103.16%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.